The Federal Trade Commission (FTC) filed a lawsuit against Hims & Hers Health, Inc. on July 29, 2026, accusing the company of illegally sharing customers' medical information with third-party advertisers like Snap and Meta Platforms. This lawsuit alleges deceptive and unlawful privacy practices, leading to a nearly 15% drop in Hims' stock price, harming investors. The Law Offices of Frank R. Cruz is investigating potential securities law violations and urging affected investors to contact them for possible claims to recover losses.
Rosen Law Firm has filed a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' health information with third-party advertisers and charging for prescriptions prematurely. The lawsuit claims these actions misled inve...
Hims & Hers Health, Inc. is under investigation following a lawsuit filed by the FTC and state authorities alleging the company misled consumers by charging for prescriptions immediately after intake forms and making subscription cancellations diffic...
The FDA issued warnings to telehealth companies and compounding pharmacies about the use of unapproved compounded weight-loss drugs, including versions of semaglutide, tirzepatide, and retatrutide. Hims & Hers Health shares fell 3.2% following the an...
